跳转至内容
Merck
CN

330728P

Avanti

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

Avanti Polar Lipids

登录查看公司和协议定价

别名:
D-galactosyl-β-1,1′-N-tridecanoyl-D-erythro-sphingosine-d7
经验公式(希尔记法):
C37H64D7NO8
分子量:
665.00
UNSPSC代码:
12352211
NACRES:
NA.12

检测方案

99% (TLC)

形式

powder

包装

pkg of 1 × 1 mg (330728P-1MG)

制造商/商品名称

Avanti Polar Lipids

运输

dry ice

储存温度

−20°C

SMILES字符串

[H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO

一般描述

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0) is deuterated derivative of C13 Galactosyl(β) Ceramide. β-Galactosyl ceramide (β −GalCer) is one of the uncomplicated glycosphingolipid. It contains a lipophilic sphingosine and a hydrophilic galactose moiety, which is attached to sphingosine via an ether linkage. It is localized in the myelin sheath of the peripheral and central nervous system.

生化/生理作用

β-Galactosyl ceramide (β −GalCer) plays a role in regulating the activity of β-glucocerebrosidase (β-GlcCer′ase). It is also a receptor for various bacterial and viral toxins.

包装

5 mL Amber Glass Screw Cap Vial

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Design, synthesis, and evaluation of beta-galactosylceramide mimics promoting beta-glucocerebrosidase activity in keratinocytes
Fukunaga K, et al.
Bioorganic & Medicinal Chemistry Letters, 13(5), 813-815 (2003)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门